Developing an Assessment of Contraceptive Preferences in Botswana: Piloting a Novel Approach Using Best-Worst Scaling of Attributes.

Africa Botswana contraception family planning patient preference

Journal

Frontiers in global women's health
ISSN: 2673-5059
Titre abrégé: Front Glob Womens Health
Pays: Switzerland
ID NLM: 101776281

Informations de publication

Date de publication:
2022
Historique:
received: 15 11 2021
accepted: 22 04 2022
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

To develop an attribute-based method for assessing patient contraceptive preferences in Botswana and pilot its use to explore the relationship between patient contraceptive preferences and the contraceptive methods provided or recommended to patients by clinicians. A list of contraceptive attributes was developed with input from patients, clinicians, and other stakeholders. We assessed patient preferences for attributes of contraceptives using a discrete choice "best-worst scaling" approach and a multi-attribute decision-making method that linked patient attribute preferences to actual contraceptive method characteristics. Attribute-based patient method preferences and clinician recommendations were compared in 100 women seeking contraceptive services, and 19 clinicians who provided their care. For 41 of the patients, the short-term reliability of their preference scores was also examined. For 57 patients who wanted more children in the future, the degree of concordance between patients and clinicians was 7% when comparing the top attribute-based contraceptive preference for each woman with the clinician-provided/recommended method. When the top two model-based preferred contraceptive methods were considered, concordance was 28%. For 43 women who did not want more children, concordance was 0% when using the patient's model-based "most-preferred" method, and 14% when considering the top two methods. Assessment of the short-term reliability of preference scores yielded an intraclass correlation coefficient of 0.93. A best-worst scaling assessment of attributes of contraceptives was designed and piloted in Botswana as a Contraceptive Preference Assessment Tool. The preference assessment was found to have high short-term reliability, which supports its potential use as a measurement tool. There was very low concordance between women's attribute-based contraceptive preferences and their clinician's provision/recommendations of contraceptive methods. Using such a preference assessment tool could encourage greater patient involvement and more tailored discussion in contraceptive consultations.

Identifiants

pubmed: 35663924
doi: 10.3389/fgwh.2022.815634
pmc: PMC9157818
doi:

Types de publication

Journal Article

Langues

eng

Pagination

815634

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010543
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH108996
Pays : United States

Informations de copyright

Copyright © 2022 Gertz, Soffi, Mompe, Sickboy, Gaines, Ryan, Mussa, Bawn, Gallop, Morroni and Crits-Christoph.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur J Contracept Reprod Health Care. 2012 Feb;17(1):65-78
pubmed: 22239264
Contraception. 2014 Sep;90(3):280-7
pubmed: 24863169
BMC Med Res Methodol. 2008 Nov 18;8:76
pubmed: 19017376
J Fam Plann Reprod Health Care. 2014 Apr;40(2):96-101
pubmed: 24265469
Sex Transm Dis. 2006 Jun;33(6):350-6
pubmed: 16505747
BMC Womens Health. 2014 Feb 13;14(1):28
pubmed: 24524562
BMC Public Health. 2016 Jan 16;16:44
pubmed: 26774918
Med Hypotheses. 2016 Sep;94:86-8
pubmed: 27515209
Arch Gynecol Obstet. 2018 Oct;298(4):731-736
pubmed: 30074068
Contraception. 2008 Jul;78(1):73-8
pubmed: 18555821
Afr J Reprod Health. 2018 Jun;22(2):76-82
pubmed: 30052336
Eur J Contracept Reprod Health Care. 2013 Jun;18(3):181-90
pubmed: 23557397
Contraception. 2012 Dec;86(6):631-8
pubmed: 22770797
Reprod Health. 2013 Feb 05;10:7
pubmed: 23384291
Am J Obstet Gynecol. 2019 Jun;220(6):565.e1-565.e12
pubmed: 30763545
Contraception. 2013 Aug;88(2):250-6
pubmed: 23177265
Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):593-596
pubmed: 28537213
Sex Transm Infect. 2008 Oct;84 Suppl 2:ii49-53
pubmed: 18799493

Auteurs

Alida M Gertz (AM)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Ahmad Syahir Mohd Soffi (ASM)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

Atlang Mompe (A)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

Ontiretse Sickboy (O)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

Averi N Gaines (AN)

Department of Psychological and Brain Sciences, University of Massachusetts Amherst, Amherst, MA, United States.

Rebecca Ryan (R)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Aamirah Mussa (A)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Caitlin Bawn (C)

Sexual and Reproductive Health Department, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, United Kingdom.

Robert Gallop (R)

West Chester University, West Chester, PA, United States.

Chelsea Morroni (C)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Medical Research Council (MRC) University of Edinburgh Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh, United Kingdom.

Paul Crits-Christoph (P)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Classifications MeSH